Metro Cardiovascular Research Foundation (EIN 341559229) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1988

Legal Domicile

Principal Officer

Meera Kondapaneni MD

Phone

2167787493

Tax Period

2024-08-01 to 2025-07-31

Metro Cardiovascular Research Foundation, founded in 1988, is a micro nonprofit in the Medical Research sector that reported $12K in total revenue in fiscal year 2024. Revenue surged 598% from the prior year, signaling strong growth momentum. The organization ran a surplus of $6K, a strong 50% operating margin.

Mission

To find a cure for cardiovascular disease.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $11,873

Other Revenue $0

TOTAL REVENUE $11,873

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $950

Other Expenses $5,897

TOTAL EXPENSES $5,897

Year-over-Year Comparison

	2024	2023	Change
Revenue	$11,873	$1,701	+6.0%
Expenses	$5,897	$5,959	0.0%
Net Income	$5,976	$-4,258	-2.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Meera Kondapaneni	President	N/A	Officer Director	$0	$0	$0
Kenneth Laurita	Vice-President	N/A	Officer Director	$0	$0	$0
M Farhan Nasser	Secretary	N/A	Officer Director	$0	$0	$0
Ashish Aneja	Treasurer	N/A	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$11,873	$5,897	$354,997	$5,976
2024	$1,701	$5,959	$334,970	$-4,258
2023	$9,765	$5,282	$297,822	$4,483
2022	$13,401	$5,660	$292,856	$7,741
2021	$8,872	$5,615	$326,967	$3,257
2020	$9,846	$4,908	$271,092	$4,938
2019	$13,842	$5,488	$273,946	$8,354

Metro Cardiovascular Research Foundation